BioAffinity Technologies financial statements provide useful quarterly and yearly information to potential bioAffinity Technologies Warrant investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BioAffinity Technologies financial statements helps investors assess BioAffinity Technologies' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BioAffinity Technologies' valuation are summarized below:
Gross Profit
3.3 M
Profit Margin
(0.90)
Revenue
9.4 M
Quarterly Revenue Growth
6.874
Revenue Per Share
0.87
There are over one hundred nineteen available fundamental signals for bioAffinity Technologies Warrant, which can be analyzed over time and compared to other ratios. All traders should should validate BioAffinity Technologies' prevailing fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to drop to about 14 M in 2025. Enterprise Value is likely to drop to about 12.7 M in 2025
About BioAffinity Technologies Financial Statements
BioAffinity Technologies investors use historical fundamental indicators, such as BioAffinity Technologies' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioAffinity Technologies. Please read more on our technical analysis and fundamental analysis pages.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.